Literature DB >> 19494509

Proteomic Approach to FcepsilonRI aggregation-initiated signal transduction cascade in human mast cells.

Kazuko Yamaoka1, Yoshimichi Okayama, Osamu Kaminuma, Kazufumi Katayama, Akio Mori, Hideki Tatsumi, Sohichi Nemoto, Takachika Hiroi.   

Abstract

BACKGROUND: Mast cells (MCs) play a central role in allergic reactions through high-affinity IgE receptor (FcepsilonRI)-mediated responses. Many attempts have been performed to investigate MC functions, though molecular bases of the intracellular signaling cascade through FcepsilonRI, especially in human MCs, remain scant and unexplored.
METHODS: Human MCs were differentiated from CD34+ cells by culture with stem cell factor, IL-6 and IL-3. The differential phosphorylation profiles of protein tyrosine residues in the resulting MCs with or without FcepsilonRI aggregation were examined by two-dimensional gel electrophoresis. The candidate phosphoproteins of interest were picked, in-gel digested and mass spectrometry fingerprinted.
RESULTS: Approximately 40 proteins in MCs were phosphorylated on their tyrosine residues in response to activation and some of them were identified. Particularly IL-31 receptor alpha, solute carrier family 39, syntaxin 5 and heterogeneous nuclear ribonucleoprotein are newly identified as phosphoproteins that are potentially involved in the MC signaling cascade through FcepsilonRI.
CONCLUSION: Our present phosphoproteome data may provide the clue to understand the molecular mechanisms for the activation of human MCs. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494509     DOI: 10.1159/000211376

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Definition and characterization of an inhibitor for interleukin-31.

Authors:  Emilie Venereau; Caroline Diveu; Linda Grimaud; Elisa Ravon; Josy Froger; Laurence Preisser; Yannic Danger; Mike Maillasson; Laure Garrigue-Antar; Yannick Jacques; Sylvie Chevalier; Hugues Gascan
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

2.  Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation.

Authors:  Nicholas J Shubin; Veronika A Glukhova; Morgan Clauson; Phuong Truong; Magnus Abrink; Gunnar Pejler; Nathan J White; Gail H Deutsch; Stephen R Reeves; Tomas Vaisar; Richard G James; Adrian M Piliponsky
Journal:  J Allergy Clin Immunol       Date:  2016-05-13       Impact factor: 10.793

Review 3.  IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Micah Belzberg; Madan M Kwatra; Shawn G Kwatra
Journal:  Drugs       Date:  2021-04-21       Impact factor: 9.546

4.  Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice.

Authors:  K Kasutani; E Fujii; S Ohyama; H Adachi; M Hasegawa; H Kitamura; N Yamashita
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

5.  Correlation between serum interleukin-31 level and the severity of disease in children with atopic dermatitis.

Authors:  Katarzyna Siniewicz-Luzeńczyk; Anna Stańczyk-Przyłuska; Krzysztof Zeman
Journal:  Postepy Dermatol Alergol       Date:  2013-10-30       Impact factor: 1.837

6.  No difference in human mast cells derived from peanut allergic versus non-allergic subjects.

Authors:  Lau F Larsen; Nanna Juel-Berg; Anker Hansen; Kirsten S Hansen; E N Clare Mills; Ronald van Ree; Madeleine Rådinger; Lars K Poulsen; Bettina M Jensen
Journal:  Immun Inflamm Dis       Date:  2018-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.